This symposium represents the third in a series of conferences sponsored or cosponsored by the National Institute of Arthritis and Metabolic Diseases, of the National Institutes of Health, in the field of chronic renal failure and dialysis. In November 1964 the Institute sponsored a conference on the state of the art in hemodialysis. That conference coincided with the initiation by this Institute of the Artificial Kidney—Chronic Uremia Program, designed to provide contract support of intensified efforts in these critical areas. In the fall of 1967, the Kidney Disease Control Program of the National Center for Chronic Disease Control and this Institute cosponsored a two-day conference on the nutritional aspects of uremia.
The present colloquium is the third of the series and that which follows comprises the transactions of that two-day conference, held in November 1968. It is concerned with the unique aberrations of divalent ion and bone metabolism found in
Whedon GD. Introductory Remarks. Arch Intern Med. 1969;124(3):261. doi:10.1001/archinte.1969.00300190001001
Customize your JAMA Network experience by selecting one or more topics from the list below.